Publications by Köhnke, T.

2017

Bücklein, V. L.; Krause, S.; Ölschlägel, U.; Köhnke, T.; Schnorfeil, F.; Völkl, S.; Rieger, M. A.; Berg, T.; Hoffmann, J.; Brendel, C.; Hiddemann, W.; Subklewe, M.; Bonin, M. von (2017): Defining minimal residual disease by flow cytometry in acute myeloid leukemia: the HARMONIZE initiative. In: Oncology Research and Treatment, Vol. 40: p. 43

Pachzelt, L.; Krupka, C.; Kischel, R.; Kufer, P.; Köhnke, T.; Polzer, H.; Spiekermann, K.; Hiddemann, W.; Subklewe, M. (2017): Costimulation Increases Intracellular Signalling In Bite (R) Antibody Construct Mediated T-Cell Activation. In: Haematologica, Vol. 102: p. 361

Costanzi, M.; Krupka, C.; Kischel, R.; Kufer, P.; Köhnke, T.; Spiekermann, K.; Hiddemann, W.; Subklewe, M. (2017): Secretion Of Soluble Factors By AML Cells Influence CD33/CD3 BITE (R) Antibody Mediated Cytotoxicity And T-Cell Proliferation. In: Haematologica, Vol. 102: pp. 357-358

Krupka, C.; Lindl, B.; Kischel, R.; Kufer, P.; Lichtenegger, F. S.; Köhnke, T.; Augsberger, C.; Altmann, T.; Spiekermann, K.; Hiddemann, W.; Subklewe, Marion (2017): Influence of Cytoreductive and Immunmodulatory Drugs on Bispecific T-Cell Engager-Based Approaches in AML. In: Annals of Hematology, Vol. 96: S81-S82

Tischer, Johanna; Zoellner, A. K.; Prevalsek, D.; Köhnke, T.; Fritsch, S.; Schulz, C.; Lippl, S.; Kruger, S.; Haebe, S.; Berking, S.; Fraccaroli, A.; Ledderose, G.; Spiekermann, K.; Bug, G.; Hausmann, A.; Schmid, C.; Albert, M.; Hiddemann, W. (2017): Haploidentical Stem Cell Transplantation in ALL. In: Annals of Hematology, Vol. 96: S39-S40

2016

Krupka, C.; Kufer, P.; Kischel, R.; Zugmaier, G.; Lichtenegger, F. S.; Köhnke, T.; Vick, B.; Jeremias, I.; Metzeler, K. H.; Altmann, T.; Schneider, S.; Fiegl, M.; Spiekermann, K.; Bauerle, P. A.; Hiddemann, W.; Riethmüller, G.; Subklewe, M. (2016): Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism. In: Leukemia, Vol. 30, No. 2: pp. 484-491

Haebe, S.; Totok, G.; Prevalsek, D.; Fritsch, S.; Hubmann, M.; Zöllner, A.-K.; Köhnke, T.; Schulz, C.; Ledderose, G.; Hausmann, A.; Hiddemann, W.; Tischer, J. (2016): HLA-haploidentical transplantation using T-cell-replete grafts and high-dose cyclophosphamide post-transplantation in the treatment of multiple myeloma: a single center experience. In: Bone Marrow Transplantation, Vol. 51: S356-S357

Prevalsek, D.; Fritsch, S.; Hubmann, M.; Zoellner, A.-K.; Köhnke, T.; Engel, N.; Bücklein, V. L.; Schulz, C.; Mumm, F.; Berking, S.; Ledderose, G.; Stemmler, H.-J.; Spiekermann, K.; Hiddemann, W.; Hausmann, A.; Tischer, J. (2016): Results of sequential therapy in the setting of unmanipulated HLA-haploidentical transplantation utilizing post-transplantation high-dose cyclophosphamide in the treatment of high-risk AML and MDS. In: Oncology Research and Treatment, Vol. 39: pp. 77-78

Krupka, C.; Lindl, B.; Platzer, J.; Brauneck, F.; Kischel, R.; Kufer, P.; Lichtenegger, F. S.; Köhnke, T.; Rothe, M.; Deiser, K.; Augsberger, C.; Altmann, T.; Spiekermann, K.; Hiddemann, W.; Subklewe, M. (2016): Influence of cytoreductive and immunmodulatory drugs on antibody-based approaches in AML. In: Oncology Research and Treatment, Vol. 39: pp. 84-85

Lichtenegger, F. S.; Deiser, K.; Rothe, M.; Krupka, C.; Schnorfeil, F. M.; Augsberger, C.; Köhnke, T.; Bücklein, V; Altmann, T.; Moosmann, A.; Brüggemann, M.; Heemskerk, M. H. M.; Wagner, B.; Hiddemann, W.; Bigalke, I; Kvalheim, G.; Subklewe, M. (2016): Induction of antigen-specific T-cell responses through dendritic cell vaccination in AML: results of a phase I/II trial and ex vivo enhancement by checkpoint blockade. In: Oncology Research and Treatment, Vol. 39: p. 135